Ikarian Capital’s Praxis Precision Medicines PRAX Stock Holding History
Bought
Maintained
Sold
Other funds holding PRAX
BBA
Ikarian Capital's PRAX Position: Q3 2026 in Review
Ikarian Capital reduced its Praxis Precision Medicines (PRAX) stake by 90% in Q3 2026, selling an estimated $21.8M and leaving 6,942 shares worth $2.02M. The position accounts for 0.2% of the portfolio, ranked #104.
Ikarian Capital first reported a position in PRAX in Q4 2020 and has held it in 12 quarters since. The position peaked at $25.5M in Q4 2025. 339 funds tracked by Wall St. Rank hold PRAX as of Q3 2026.
- Ikarian Capital held 6,942 shares of Praxis Precision Medicines worth $2.02M as of Q3 2026.
- Ikarian Capital sold 65,900 Praxis Precision Medicines shares in Q3 2026, an estimated $21.8M.
- Praxis Precision Medicines made up 0.2% of Ikarian Capital's portfolio in Q3 2026, its #104 holding.
- Ikarian Capital first reported a position in Praxis Precision Medicines in Q4 2020 and has held it in 12 quarters since.
- Ikarian Capital's Praxis Precision Medicines position peaked at $25.5M in Q4 2025.
- 339 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q3 2026.
Based on Ikarian Capital's 13F filing for Q3 2026, filed 16 Nov 2026.